Buy
Business
M
Moneycontrol01-02-2026, 12:20

Anand Rathi Recommends 'BUY' on Sharda Cropchem, Sets Target at Rs 1330

  • Sharda Cropchem outperformed in Q3FY26 with 14% YoY volume growth, favorable product mix, and market share gains.
  • Improved demand in Europe and Latin America, along with near-complete de-stocking, bolstered growth momentum.
  • Management anticipates price hikes and increased volumes due to expanded reach and market penetration.
  • Confident of sustaining growth in Q4FY26e and FY27e, driven by improved demand and pricing.
  • Anand Rathi projects 15/27/34% revenue/EBITDA/PAT CAGR over FY25-28e, maintaining a 'BUY' rating with a revised target of Rs 1,330.

Why It Matters: Anand Rathi recommends buying Sharda Cropchem, citing strong growth and future potential, with a target of Rs 1330.

More like this

Loading more articles...